No takes yet. Share an insight, caveat, or question.
Randomized trial examines TAFI antigen levels and their link to cardiovascular risk factors in patients, suggesting genetic control may be significant.
Juhan-Vague et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: